Clinical Trial Update: Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation [Phase 2]

View source ↗

Summary

This update notes the completion of a Phase 2 study evaluating difluprednate ophthalmic emulsion for postoperative inflammation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Inflammation

Drugs mentioned

• Difluprednate ophthalmic emulsion (difluprednate)

Snippet

Sponsor: Sirion Therapeutics, Inc. | Conditions: Inflammation | Phase 2 | Status: COMPLETED